Trans-Acting Factors Causing Cell-Specific Gene Control
$40,000R01FY2021GMNIH
University Of Pennsylvania, Philadelphia PA
Investigators
Linked publications & trials
Paper 39345615Paper 38329880Paper 38267705Paper 37940484Paper 37410825Paper 37405916Paper 37365888Paper 36990958Paper 36626868Paper 36536103Paper 35863165Paper 35440147Paper 34485932Paper 33377115Paper 32886547Paper 32574554Paper 32203463Paper 31303471Paper 31103921Paper 30797686Paper 30689973Paper 30606806Paper 30420736Paper 29636575Paper 29374252Paper 29348325Paper 28912132Paper 28701476Paper 28408562Paper 27973548Paper 27259199Paper 27246709Paper 27058788Paper 26826681Paper 26675384Paper 26089518Paper 25712212Paper 25031271Paper 23159369Paper 21935353Paper 19339686Paper 19056973Paper 19028990Paper 18300424Paper 17179747Paper 16950125Paper 16386727Paper 16364283Paper 15766750Paper 15380251Paper 14736744Paper 14736742Paper 12944473Paper 12791650Paper 12619131Paper 11577199Paper 11532400Paper 11485993Paper 11222142Paper 11044405Paper 10704889
Abstract
Summary Dr. Ken Zaret (R01GM36477) and his NIGMS-funded collaborator Dr. Matt Good (R35- GM128748) request supplemental funding to purchase a Surface Plasmon Resonance device, to allow inter-molecular interactions to be quantified more accurately and faster than we can do by present means. The equipment would help advance our research substantially. This is a one-time request for equipment that costs $46,954, with $40,000 requested from NIGMS and the remainder from our Department (see Chair's letter).
View original record on NIH RePORTER →